What is the appropriate workup for acute kidney injury (AKI) in a hospitalized patient?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 4, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Workup of Acute Kidney Injury in Hospitalized Patients

Begin with immediate measurement of serum creatinine, complete blood count, urinalysis with microscopy, and fractional excretion of sodium (FENa), followed by renal ultrasonography in most patients to rule out obstruction. 1

Initial Diagnostic Classification

The workup should systematically classify AKI as prerenal, intrinsic renal, or postrenal through a structured approach 1:

History and Medication Review

  • Identify all nephrotoxic medications including NSAIDs, aminoglycosides, vancomycin, and ACE inhibitors/ARBs that require immediate discontinuation 1, 2
  • Document recent contrast exposure within the preceding 48-72 hours, as contrast-induced AKI is preventable with proper recognition 3
  • Assess for systemic illnesses causing poor renal perfusion (sepsis, heart failure, cirrhosis) or direct renal injury (vasculitis, glomerulonephritis) 1

Physical Examination Priorities

  • Evaluate intravascular volume status through jugular venous pressure, mucous membranes, skin turgor, and orthostatic vital signs to distinguish prerenal from intrinsic causes 1
  • Examine for skin rashes suggesting systemic vasculitis or atheroembolic disease 1
  • Assess for bladder distention indicating possible urinary obstruction 1

Laboratory Workup

Essential Initial Tests

  • Serum creatinine with comparison to baseline - AKI is defined as ≥0.3 mg/dL increase within 48 hours or ≥1.5× baseline within 7 days 4
  • Urinalysis with microscopy - Look for:
    • Muddy brown casts (acute tubular necrosis)
    • Red blood cell casts (glomerulonephritis)
    • White blood cell casts (acute interstitial nephritis)
    • Eosinophils (allergic interstitial nephritis) 1
  • Fractional excretion of sodium (FENa) - FENa <1% suggests prerenal azotemia, while >2% indicates intrinsic renal disease 1
  • Complete blood count - Assess for anemia (hemolysis, chronic disease) and thrombocytopenia (thrombotic microangiopathy) 1

Imaging

  • Renal ultrasonography should be performed in most patients, particularly older men, to exclude obstructive uropathy 1
  • Ultrasound also evaluates kidney size (small kidneys suggest chronic disease) and echogenicity 1

Electronic Alert Systems

Hospitals should implement automated KDIGO-based electronic alerts that identify AKI through delta checks showing absolute creatinine rise ≥0.3 mg/dL within 48 hours 3. These alerts have successfully reduced nephrotoxic medication use and prevented contrast-induced AKI 3.

Staging and Risk Stratification

Apply KDIGO staging criteria immediately 4:

  • Stage 1: Creatinine 1.5-1.9× baseline or ≥0.3 mg/dL increase; urine output <0.5 mL/kg/hr for 6-12 hours
  • Stage 2: Creatinine 2.0-2.9× baseline; urine output <0.5 mL/kg/hr for ≥12 hours
  • Stage 3: Creatinine ≥3.0× baseline or ≥4.0 mg/dL or initiation of RRT; urine output <0.3 mL/kg/hr for ≥24 hours or anuria for ≥12 hours

Common Pitfalls to Avoid

  • Do not assume transient AKI is benign - even rapidly reversible AKI with recovery within 3 days carries 15% hospital mortality versus 4% without AKI 3
  • Recognize that acute-on-chronic kidney disease (ACKD) is particularly high-risk and warrants aggressive management even if percentage creatinine rises appear modest 3
  • Avoid using imputed baseline creatinine when possible - this may overestimate kidney function and create false-positive AKI alerts, though some false positives are acceptable for safety 3
  • Do not delay workup for obstruction in older men - postrenal causes are readily reversible if identified early 1

Hemodynamic Assessment

Use isotonic crystalloids rather than colloids (albumin or hydroxyethyl starches) for initial volume expansion in patients at risk for or with established AKI 3. The 6S Trial demonstrated that HES 130/0.42 increased mortality, need for renal replacement therapy, and bleeding compared to Ringer's acetate 3. Despite theoretical advantages, colloids show no mortality benefit and add unnecessary cost 3.

References

Research

Acute kidney injury: a guide to diagnosis and management.

American family physician, 2012

Research

Management of Acute Kidney Injury: Core Curriculum 2018.

American journal of kidney diseases : the official journal of the National Kidney Foundation, 2018

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.